XML 60 R41.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Business segment information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2018
Segment Reporting [Abstract] |
Schedule Of Net Sales by Reporting Segment | The table below presents net sales by reporting segment:
|  | Year Ended December 31, |
|  | 2018 |  |  | 2017 |  |  | 2016 |
(U.S. Dollars, in thousands) |  | Net Sales |  |  | Percent of Total Net Sales |  |  | Net Sales |  |  | Percent of Total Net Sales |  |  | Net Sales |  |  | Percent of Total Net Sales |
Bone Growth Therapies |  | $ | 195,252 |  |  |  | 43.1 | % |  | $ | 185,900 |  |  |  | 42.9 | % |  | $ | 176,561 |  |  |  | 43.1 | %
Spinal Implants |  |  | 91,658 |  |  |  | 20.2 | % |  |  | 81,957 |  |  |  | 18.9 | % |  |  | 72,632 |  |  |  | 17.7 | %
Biologics |  |  | 59,684 |  |  |  | 13.2 | % |  |  | 62,724 |  |  |  | 14.4 | % |  |  | 57,912 |  |  |  | 14.1 | %
Orthofix Extremities |  |  | 106,448 |  |  |  | 23.5 | % |  |  | 103,242 |  |  |  | 23.8 | % |  |  | 102,683 |  |  |  | 25.1 | %
Net sales |  | $ | 453,042 |  |  |  | 100.0 | % |  | $ | 433,823 |  |  |  | 100.0 | % |  | $ | 409,788 |  |  |  | 100.0 | %
Summary of Non-GAAP Net Margin by Reporting Segment | The following table presents Non-GAAP net margin, and internal metric that the Company defines as gross profit less sales and marketing expense, by reporting segment:
|  | Year Ended December 31, |
(U.S. Dollars, in thousands) |  | 2018 |  |  | 2017 |  |  | 2016 |
Bone Growth Therapies |  | $ | 86,252 |  |  | $ | 77,369 |  |  | $ | 75,469 |
Spinal Implants |  |  | 7,628 |  |  |  | 8,730 |  |  |  | 8,650 |
Biologics |  |  | 26,298 |  |  |  | 25,692 |  |  |  | 26,891 |
Orthofix Extremities |  |  | 31,391 |  |  |  | 31,071 |  |  |  | 30,526 |
Corporate |  |  | (682 | ) |  |  | (446 | ) |  |  | (888 | )
Non-GAAP net margin |  | $ | 150,887 |  |  | $ | 142,416 |  |  | $ | 140,648 |
General and administrative |  |  | 84,506 |  |  |  | 71,905 |  |  |  | 76,409 |
Research and development |  |  | 33,218 |  |  |  | 29,700 |  |  |  | 28,803 |
Changes in fair value of contingent consideration |  |  | 3,069 |  |  |  | — |  |  |  | — |
Charges related to U.S. Government resolutions |  |  | — |  |  |  | — |  |  |  | 14,369 |
Operating income |  | $ | 30,094 |  |  | $ | 40,811 |  |  | $ | 21,067 |
Interest income (expense), net |  |  | (828 | ) |  |  | (416 | ) |  |  | 763 |
Other expense, net |  |  | (6,381 | ) |  |  | (4,004 | ) |  |  | (2,806 | )
Income before income taxes |  | $ | 22,885 |  |  | $ | 36,391 |  |  | $ | 19,024 |
Schedule of Depreciation and Amortization by Reporting Segment | The following table presents depreciation and amortization by reporting segment:
|  | Year Ended December 31, |
(U.S. Dollars, in thousands) |  | 2018 |  |  | 2017 |  |  | 2016 |
Bone Growth Therapies |  | $ | 1,770 |  |  | $ | 2,133 |  |  | $ | 2,754 |
Spinal Implants |  |  | 7,294 |  |  |  | 6,949 |  |  |  | 8,118 |
Biologics |  |  | 448 |  |  |  | 752 |  |  |  | 1,011 |
Orthofix Extremities |  |  | 5,342 |  |  |  | 6,040 |  |  |  | 5,742 |
Corporate |  |  | 3,805 |  |  |  | 4,250 |  |  |  | 3,216 |
Total |  | $ | 18,659 |  |  | $ | 20,124 |  |  | $ | 20,841 |
Summary of Net Sales by Geographic Destination | The following data includes net sales by geographic destination:
(U.S. Dollars, in thousands) |  | 2018 |  |  | 2017 |  |  | 2016 |
U.S. |  | $ | 355,353 |  |  | $ | 345,145 |  |  | $ | 316,873 |
Italy |  |  | 19,331 |  |  |  | 17,059 |  |  |  | 16,664 |
Germany |  |  | 11,606 |  |  |  | 7,063 |  |  |  | 6,448 |
United Kingdom |  |  | 8,731 |  |  |  | 8,725 |  |  |  | 10,362 |
Brazil |  |  | 7,120 |  |  |  | 10,356 |  |  |  | 11,334 |
Others |  |  | 50,901 |  |  |  | 45,475 |  |  |  | 48,107 |
Net sales |  | $ | 453,042 |  |  | $ | 433,823 |  |  | $ | 409,788 |
The table below presents net sales by geographic destination for each reporting segment and for the consolidated Company:
(U.S. Dollars, in thousands) |  | 2018 |  |  | 2017 |  |  | 2016 |
Bone Growth Therapies |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 195,189 |  |  | $ | 185,853 |  |  | $ | 176,510 |
International |  |  | 63 |  |  |  | 47 |  |  |  | 51 |
Total Bone Growth Therapies |  |  | 195,252 |  |  |  | 185,900 |  |  |  | 176,561 |
Spinal Implants |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 72,137 |  |  |  | 69,704 |  |  |  | 57,772 |
International |  |  | 19,521 |  |  |  | 12,253 |  |  |  | 14,860 |
Total Spinal Implants |  |  | 91,658 |  |  |  | 81,957 |  |  |  | 72,632 |
Biologics |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 59,668 |  |  |  | 62,670 |  |  |  | 57,574 |
International |  |  | 16 |  |  |  | 54 |  |  |  | 338 |
Total Biologics |  |  | 59,684 |  |  |  | 62,724 |  |  |  | 57,912 |
Orthofix Extremities |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 28,359 |  |  |  | 26,918 |  |  |  | 25,017 |
International |  |  | 78,089 |  |  |  | 76,324 |  |  |  | 77,666 |
Total Orthofix Extremities |  |  | 106,448 |  |  |  | 103,242 |  |  |  | 102,683 |
Consolidated |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 355,353 |  |  |  | 345,145 |  |  |  | 316,873 |
International |  |  | 97,689 |  |  |  | 88,678 |  |  |  | 92,915 |
Net sales |  | $ | 453,042 |  |  | $ | 433,823 |  |  | $ | 409,788 |
Summary of Property, Plant and Equipment of Reporting Segments by Geographic Area | The following data includes property, plant and equipment by geographic area:
(U.S. Dollars, in thousands) |  | 2018 |  |  | 2017 |
U.S. |  | $ | 31,344 |  |  | $ | 34,008 |
Italy |  |  | 7,732 |  |  |  | 7,658 |
Germany |  |  | 861 |  |  |  | 933 |
United Kingdom |  |  | 896 |  |  |  | 382 |
Brazil |  |  | 191 |  |  |  | 475 |
Others |  |  | 1,811 |  |  |  | 1,683 |
Total |  | $ | 42,835 |  |  | $ | 45,139 |

X
- Definition Non GAAP net margin by segment reporting. + References No definition available. + Details
Name: | ofix_NonGAAPNetMarginBySegmentReportingTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of segment reporting information by segment depreciation and amortization. + References No definition available. + Details
Name: | ofix_ScheduleOfSegmentReportingInformationBySegmentDepreciationAndAmortizationTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenues by reporting segment. + References No definition available. + Details
Name: | ofix_ScheduleOfSegmentReportingRevenuesBySegmentTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph b -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph a -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration